Solventum Corporation (SOLV)

Market Cap	11.49B
Revenue (ttm)	8.39B
Net Income (ttm)	380.00M
Shares Out	173.39M
EPS (ttm)	2.18
PE Ratio	30.34
Forward PE	10.70
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,792,153
Open	67.47
Previous Close	67.69
Day's Range	66.11 - 68.31
52-Week Range	60.70 - 85.92
Beta	n/a
Analysts	Hold
Price Target	84.25 (+27.11%)
Earnings Date	Nov 6, 2025

About SOLV

Solventum Corporation, a healthcare company, develops, manufactures, and commercializes a portfolio of solutions to address critical customer and patient needs in the United States and internationally. It operates in four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration. The Medsurg segment offers solutions for negative pressure wound therapy, advanced wound dressings, advanced skin care, I.V. site management, sterilization assurance, temperature management, surgical supplies, medical tapes and wr...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 2023
• Employees: 22,000
• Stock Exchange: NYSE
• Ticker Symbol: SOLV
• Website: https://www.solventum.com

Financial Performance

In 2024, Solventum's revenue was $8.25 billion, an increase of 0.70% compared to the previous year's $8.20 billion. Earnings were $479.00 million, a decrease of -64.41%.

Analyst Summary

According to 10 analysts, the average rating for SOLV stock is "Hold." The 12-month stock price target is $84.25, which is an increase of 27.11% from the latest price.

Price Target

$84.25

(27.11% upside)

Analyst Consensus: Hold